Healthcare resource utilization in patients treated with empagliflozin in East Asia.
Wayne Huey Herng SheuYutaka SeinoElise Chia-Hui TanDaisuke YabeKyoung Hwa HaMasaomi NangakuWook-Jin ChungKoichi NodeAtsutaka YasuiWei-Yu LeiSunwoo LeeAnastasia UstyugovaRiho KlementAnouk Deruaz-LuyetMoe H KyawDae-Jung Kimnull nullPublished in: Journal of diabetes investigation (2021)
Empagliflozin treatment was associated with lower inpatient care needs and other healthcare resource utilization than DPP-4 inhibitors in routine clinical practice in East Asia in this study.